Ifetroban clinical trials
Includes 3 studies of Ifetroban sodium.
How each study uses ifetroban is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the ifetroban studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Ifetroban
- 5
Studies by the year they started
10 studies that test it; most in 2017 (3)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2014 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 10
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 3
Cumberland Pharmaceuticals (7) · Vanderbilt-Ingram Cancer Center (1) · Jeffrey Rade (1) · Brigham and Women's Hospital (1)
Studies
Open first, then newest update. How each study uses ifetroban is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 10
- Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)RecruitingPhase 2Cumberland PharmaceuticalsNCT05571059Written as Ifetroban SodiumHow we know
- Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial HypertensionActive, not recruitingPhase 2Cumberland PharmaceuticalsNCT02682511Written as Oral IfetrobanHow we know
- Oral Ifetroban in Subjects With Duchenne Muscular DystrophyCompletedPhase 2Cumberland PharmaceuticalsNCT03340675Written as IfetrobanHow we know
- Thromboxane Receptor Antagonist to Improve Endothelial FunctionCompletedPhase 2Jeffrey RadeNCT03962855Written as Ifetroban SodiumHow we know
- Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)CompletedPhase 2Cumberland PharmaceuticalsNCT03028350Written as Ifetroban Oral CapsuleHow we know
- Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic RecurrenceActive, not recruitingPhase 2Vanderbilt-Ingram Cancer CenterNCT03694249Written as Ifetroban SodiumHow we know
- Therapeutic Control of Aspirin-Exacerbated Respiratory Disease With IfetrobanCompletedPhase 2Brigham and Women's HospitalNCT03326063Written as IfetrobanHow we know
- Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic PatientsCompletedPhase 2Cumberland PharmaceuticalsNCT02802228Written as IfetrobanHow we know
- Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory DiseaseCompletedPhase 2Cumberland PharmaceuticalsNCT02216357Written as Ifetroban, Oral CapsuleHow we know
- Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome PatientsCompletedPhase 2Cumberland PharmaceuticalsNCT01436500Written as Ifetroban InjectionHow we know
Codes
What other systems call ifetroban · ClinicalTrials.gg INT003691
- MeSH (NLM) C078904ifetrobanConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) E833KT807KIFETROBANConfirmed FDA, NLM, Wikidata
- Wikidata Q5991162IfetrobanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C81570IfetrobanOne source FDA
- DrugBank DB12321One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C078904 | ifetroban | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | E833KT807K | IFETROBAN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q5991162 | Ifetroban | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C81570 | Ifetroban | One source FDA |
| DrugBank | DB12321 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.